CA2593166A1 - Mitotic kinesin inhibitors - Google Patents

Mitotic kinesin inhibitors Download PDF

Info

Publication number
CA2593166A1
CA2593166A1 CA002593166A CA2593166A CA2593166A1 CA 2593166 A1 CA2593166 A1 CA 2593166A1 CA 002593166 A CA002593166 A CA 002593166A CA 2593166 A CA2593166 A CA 2593166A CA 2593166 A1 CA2593166 A1 CA 2593166A1
Authority
CA
Canada
Prior art keywords
alkyl
cycloalkyl
compound
aryl
heterocyclyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002593166A
Other languages
English (en)
French (fr)
Inventor
Paul J. Coleman
George D. Hartman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2593166A1 publication Critical patent/CA2593166A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C07D239/91—Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CA002593166A 2005-01-19 2006-01-13 Mitotic kinesin inhibitors Abandoned CA2593166A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US64493405P 2005-01-19 2005-01-19
US60/644,934 2005-01-19
PCT/US2006/001483 WO2006078598A2 (en) 2005-01-19 2006-01-13 Mitotic kinesin inhibitors

Publications (1)

Publication Number Publication Date
CA2593166A1 true CA2593166A1 (en) 2006-07-27

Family

ID=36692770

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002593166A Abandoned CA2593166A1 (en) 2005-01-19 2006-01-13 Mitotic kinesin inhibitors

Country Status (7)

Country Link
US (1) US20090124641A1 (enExample)
EP (1) EP1855685A4 (enExample)
JP (1) JP2008527041A (enExample)
CN (1) CN101106998A (enExample)
AU (1) AU2006206675A1 (enExample)
CA (1) CA2593166A1 (enExample)
WO (1) WO2006078598A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2010004313A (es) * 2007-11-07 2010-07-06 Schering Corp Compuestos para inhibir la actividad de quinesina de la proteina de quinesina del huso.
US8940742B2 (en) 2012-04-10 2015-01-27 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
WO2015051241A1 (en) 2013-10-04 2015-04-09 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
SG10201902074UA (en) 2013-10-04 2019-04-29 Infinity Pharmaceuticals Inc Heterocyclic compounds and uses thereof
CN113616656B (zh) 2014-03-19 2023-02-17 无限药品股份有限公司 用于治疗PI3K-γ介导的障碍的杂环化合物
WO2016054491A1 (en) 2014-10-03 2016-04-07 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
AU2016322552B2 (en) 2015-09-14 2021-03-25 Infinity Pharmaceuticals, Inc. Solid forms of isoquinolinone derivatives, process of making, compositions comprising, and methods of using the same
WO2017161116A1 (en) 2016-03-17 2017-09-21 Infinity Pharmaceuticals, Inc. Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as pi3k kinase inhibitors
WO2017214269A1 (en) 2016-06-08 2017-12-14 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
CN113549000A (zh) * 2020-04-23 2021-10-26 复旦大学 用于预防或治疗脂质代谢相关疾病的化合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4183931A (en) * 1977-09-08 1980-01-15 Research Corporation 2-Ketoalkyl-4(3H)-quinazolinones
US5470975A (en) * 1990-10-16 1995-11-28 E.R. Squibb & Sons, Inc. Dihydropyrimidine derivatives
US6667300B2 (en) * 2000-04-25 2003-12-23 Icos Corporation Inhibitors of human phosphatidylinositol 3-kinase delta
JP2006515886A (ja) * 2003-01-17 2006-06-08 サイトキネティクス・インコーポレーテッド 化合物、組成物、および方法
WO2005046588A2 (en) * 2003-11-07 2005-05-26 Cytokinetics, Inc. Compounds, compositions, and methods

Also Published As

Publication number Publication date
AU2006206675A1 (en) 2006-07-27
EP1855685A4 (en) 2009-12-23
CN101106998A (zh) 2008-01-16
WO2006078598A2 (en) 2006-07-27
WO2006078598A3 (en) 2007-04-12
US20090124641A1 (en) 2009-05-14
EP1855685A2 (en) 2007-11-21
JP2008527041A (ja) 2008-07-24

Similar Documents

Publication Publication Date Title
AU2003297230B2 (en) Mitotic kinesin inhibitors
CA2508956A1 (en) Mitotic kinesin inhibitors
US20080102068A1 (en) Mitotic Kinesin Inhibitors
US7629373B2 (en) Mitotic kinesin inhibitors
US20080045492A1 (en) Mitotic Kinesin Inhibitors
CA2547209A1 (en) Mitotic kinesin inhibitors
US7632839B2 (en) Mitotic kinesin inhibitors
CA2593166A1 (en) Mitotic kinesin inhibitors
CA2599436A1 (en) Mitotic kinesin inhibitors
EP1773326A2 (en) Mitotic kinesin inhibitors
EP1765830B1 (en) Mitotic kinesin inhibitors
CA2571824A1 (en) Mitotic kinesin inhibitors
CA2547746A1 (en) Mitotic kinesin inhibitors
US20090005418A1 (en) Mitotic Kinesin Inhibitors
WO2006023083A1 (en) Mitotic kinesin inhibitors
CA2571821A1 (en) Prodrugs of mitotic kinesin inhibitors

Legal Events

Date Code Title Description
FZDE Discontinued